These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33895063)

  • 41. Predicting and preventing post-ERCP pancreatitis.
    Baillie J
    Curr Gastroenterol Rep; 2002 Apr; 4(2):112-9. PubMed ID: 11900675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized controlled trial for efficacy of nafamostat mesilate in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Ohuchida J; Chijiiwa K; Imamura N; Nagano M; Hiyoshi M
    Pancreas; 2015 Apr; 44(3):415-21. PubMed ID: 25479585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Zou DW; Li ZS
    Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute pancreatitis.
    Famularo G; Minisola G; De Simone C
    N Engl J Med; 2006 Aug; 355(9):961; author reply 961. PubMed ID: 16943414
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of Pharmacologic Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Systematic Review.
    Kubiliun NM; Adams MA; Akshintala VS; Conte ML; Cote GA; Cotton PB; Dumonceau JM; Elta GH; Fogel EL; Freeman ML; Lehman GA; Naveed M; Romagnuolo J; Scheiman JM; Sherman S; Singh VK; Elmunzer BJ;
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1231-9; quiz e70-1. PubMed ID: 25579870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ
    World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials.
    Yu G; Li S; Wan R; Wang X; Hu G
    Pancreas; 2015 May; 44(4):561-9. PubMed ID: 25822153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Somatostatin for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a never-ending story?
    Chen CC
    J Chin Med Assoc; 2009 Feb; 72(2):57-9. PubMed ID: 19251531
    [No Abstract]   [Full Text] [Related]  

  • 51. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Shi X; Zou D; Li Z
    Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial.
    Yoo KS; Huh KR; Kim YJ; Kim KO; Park CH; Hahn T; Park SH; Kim JH; Park CK; Kwon YJ; Lehman GA
    Pancreas; 2011 Mar; 40(2):181-6. PubMed ID: 21206331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does wire-guided cannulation prevent post-ERCP pancreatitis?: a meta-analysis.
    Madhoun MF; Maple JT
    Am J Gastroenterol; 2010 Apr; 105(4):960. PubMed ID: 20372145
    [No Abstract]   [Full Text] [Related]  

  • 55. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of post-endoscopic retrograde cholangiopancreatography pancreatitis and ways to prevent it: old myths, a current need? The case of allopurinol.
    Andriulli A; Annese V
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):374-6. PubMed ID: 18387495
    [No Abstract]   [Full Text] [Related]  

  • 57. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, non-randomized study].
    Vila JJ; Jiménez FJ; Prieto C; Borobio E; Juanmartiñena JF; Borda F
    Gastroenterol Hepatol; 2006 Apr; 29(4):231-6. PubMed ID: 16584693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
    Moretó M; Zaballa M
    Br J Surg; 2002 May; 89(5):628; author reply 629. PubMed ID: 12019509
    [No Abstract]   [Full Text] [Related]  

  • 60. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
    Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
    Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.